AACR: Drug Combo Shows Promise in Advanced Pancreatic Cancer


http://... D. Von Hoff, M.D., of the Scottsdale Clinical Research Institute in Scottsdale, Ariz.SAN DIEGO, April 17 -- More than 70% of patients with pancreatic cancer derived a clinical benefit when treated in a small, phase I trial with the combination of nanoparticle albumin bound paclitaxel (Abraxane) and gemcitabine (Gemzar), investigators reported here.







Channel: Education
Uploaded: April 18, 2008 at 8:01 am
Author: MedPageToday

Length: 00:02:39
Rating:
Views: 180

Tags: medicine health

Embed Code:


Video Comments:
Phillipnsoul (July 28, 2008 at 2:33 pm)
Hi I saw your awesome video about pancreatic cancer. We are the Hirshberg Foundation for Cancer Research at UCLA medical center. Thanks so much for doing all you do to help find a cure.

Please visit our foundation site at pancreatic "dot" org and we also do a huge run and walk for Cancer in Oct. every Halloween in So. Cal called the LA Cancer Challenge. You can read about it here LACancerChallenge "dot" com
Looking forward to hearing from you and working together to beat this disease.

1

 

Privacy Policy Cancer Video | Treatment Survival & Education Copyright © 2007 All Rights Reserved.